Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule

NCT00460486 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Encephalitis, Tick-Borne

Interventions

BIOLOGICAL: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl

Sponsor

Pfizer